id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1984-G-0019-0178,FDA,FDA-1984-G-0019,Memorandum from FDA CFSAN for GRAS affirmation petitions,Other,Memorandum,2016-10-21T04:00:00Z,2016,10,2016-10-21T04:00:00Z,,2016-10-21T13:09:45Z,,0,0,0900006482330b77
FDA-1984-G-0019-0177,FDA,FDA-1984-G-0019,Letter from FDA CFSAN to Petitioner,Other,Letter(s),2016-10-17T04:00:00Z,2016,10,2016-10-17T04:00:00Z,,2016-10-17T18:52:36Z,,0,0,09000064823048f1
FDA-1984-G-0019-0153,FDA,FDA-1984-G-0019,Letter from Enzyme Technical Association to FDA,Other,Letter(s),2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:54:07Z,,0,0,09000064805a7fdf
FDA-1984-G-0019-0150,FDA,FDA-1984-G-0019,Letter from McKenna & Cuneo L.L.P. to FDA,Other,Letter(s),2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:48:31Z,,0,0,09000064805a7fdc
FDA-1984-G-0019-0137,FDA,FDA-1984-G-0019,Memorandum of Telephone Conversation between FDA/HFS-206 & Enzyme Technical Association,Other,Memorandum,2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:48:29Z,,0,0,09000064805a7fce
FDA-1984-G-0019-0139,FDA,FDA-1984-G-0019,Letter from Enzyme Technical Association to FDA,Other,Letter(s),2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:48:30Z,,0,0,09000064805a7fd0
FDA-1984-G-0019-0127,FDA,FDA-1984-G-0019,Memorandum of Telephone Conversation between FDA/HFS-206 &  Enzyme Technical Association,Other,Memorandum,2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:46:20Z,,0,0,09000064805a7fc4
FDA-1984-G-0019-0123,FDA,FDA-1984-G-0019,Letter from Enzyme Technical Association to FDA,Other,Letter(s),2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:46:19Z,,0,0,09000064805a7fc0
FDA-1984-G-0019-0092,FDA,FDA-1984-G-0019,Memorandum from FDA/HFF-458,Other,Memorandum,2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:43:52Z,,0,0,09000064805a7fa1
FDA-1984-G-0019-0089,FDA,FDA-1984-G-0019,Memorandum from FDA/HFF-334 to FDA/HFF-231 & FDA/458,Other,Memorandum,2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:43:51Z,,0,0,09000064805a7f9e
FDA-1984-G-0019-0136,FDA,FDA-1984-G-0019,Letter from Miles Inc. to FDA/CFSAN,Other,Letter(s),2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:48:29Z,,0,0,09000064805a7fcd
FDA-1984-G-0019-0082,FDA,FDA-1984-G-0019,Memorandum from FDA/HFF-458 to FDA/HFF-335,Other,Memorandum,2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:43:02Z,,0,0,09000064805a7f97
FDA-1984-G-0019-0048,FDA,FDA-1984-G-0019,Letter from Wallerstein Company to FDA,Other,Letter(s),2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:39:12Z,,0,0,09000064805a7f77
FDA-1984-G-0019-0049,FDA,FDA-1984-G-0019,Letter from FDA/BF-335 to Ad Hoc Enzyme Technical Committee,Other,Letter(s),2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:39:12Z,,0,0,09000064805a7f76
FDA-1984-G-0019-0020,FDA,FDA-1984-G-0019,Letter from  Enzyme Technical Association to FDA,Other,Letter(s),2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:20:09Z,,0,0,09000064805a7f5f
FDA-1984-G-0019-0021,FDA,FDA-1984-G-0019,Letter from FDA/HFF-334 to Enzyme Technical Association,Other,Letter(s),2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:20:10Z,,0,0,09000064805a7f5e
FDA-1984-G-0019-0024,FDA,FDA-1984-G-0019,Supplement from Enzyme Technical Association,Other,Supplement (SUP),2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:20:11Z,,0,0,09000064805a7f5b
FDA-1984-G-0019-0039,FDA,FDA-1984-G-0019,Memorandum of Telephone Conversation between FDA/GCF-1 and McKenna and Cuneo,Other,Memorandum,2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:37:27Z,,0,0,09000064805a7f66
FDA-1984-G-0019-0041,FDA,FDA-1984-G-0019,"Letter from FDA/HFF-334 to Enzyme Technical Association (c/o McKenna, Conner & Cuneo)",Other,Letter(s),2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:37:28Z,,0,0,09000064805a7f64
FDA-1984-G-0019-0116,FDA,FDA-1984-G-0019,Memorandum of Telephone Conversation between FDA/HFS-206 &  Enzyme Technical Association,Other,Memorandum,2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:44:23Z,,0,0,09000064805a7fb9
FDA-1984-G-0019-0091,FDA,FDA-1984-G-0019,Memorandum of Meeting from FDA/HFF-334 to Industry and FDA/HFF-458,Other,Memorandum,2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:43:52Z,,0,0,09000064805a7fa0
FDA-1984-G-0019-0164,FDA,FDA-1984-G-0019,Appendix A Proposed Specifications For Pancreatin re Supplement from Enzyme Technical Association,Supporting & Related Material,Background Material,2016-08-03T04:00:00Z,2016,8,,,2016-08-03T15:55:03Z,,0,0,0900006481edac3a
FDA-1984-G-0019-0172,FDA,FDA-1984-G-0019,The 1978 Enzyme Survey Summarized Data from National Research Council re Comment from Enzyme Technical Association,Supporting & Related Material,Background Material,2016-08-03T04:00:00Z,2016,8,,,2016-08-03T15:55:04Z,,0,0,0900006481ee0544
FDA-1984-G-0019-0165,FDA,FDA-1984-G-0019,Appendix C Description of The Term Saccharomyces Species re Supplement from Enzyme Technical Association,Supporting & Related Material,Background Material,2016-08-03T04:00:00Z,2016,8,,,2016-08-03T15:55:03Z,,0,0,0900006481edac3d
FDA-1984-G-0019-0173,FDA,FDA-1984-G-0019,Exhibit P: Acknowledgment of receipt from FDA to Enzyme Technical Association,Supporting & Related Material,Background Material,2016-08-03T04:00:00Z,2016,8,,,2016-08-03T15:55:05Z,,0,0,0900006481eec52f
FDA-1984-G-0019-0115,FDA,FDA-1984-G-0019,"Letter from McKenna & Cuneo, L.L.P to FDA",Other,Letter(s),2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:44:23Z,,0,0,09000064805a7fb8
FDA-1984-G-0019-0108,FDA,FDA-1984-G-0019,Letter from FDA/HFS-216 to Enzyme Technical Association,Other,Letter(s),2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:44:22Z,,0,0,09000064805a7fb1
FDA-1984-G-0019-0080,FDA,FDA-1984-G-0019,Memorandum of Meeting from FDA/HFF-335 to HFF-144,Other,Memorandum,2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:43:01Z,,0,0,09000064805a7f95
FDA-1984-G-0019-0063,FDA,FDA-1984-G-0019,"Letter from Dairyland Food Laboratories, Inc. to FDA",Other,Letter(s),2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:40:54Z,,0,0,09000064805a7f86
FDA-1984-G-0019-0053,FDA,FDA-1984-G-0019,Letter from FDA/BF-1 to Ad Hoc Enzyme Technical Committee,Other,Letter(s),2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:39:13Z,,0,0,09000064805a7f72
FDA-1984-G-0019-0073,FDA,FDA-1984-G-0019,Letter from Enzyme Technical Association to FDA,Other,Letter(s),2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:43:00Z,,0,0,09000064805a7f8e
FDA-1984-G-0019-0057,FDA,FDA-1984-G-0019,Letter from FDA/HFF-335 to Roger D Middlekauff (Ad Hoc Enzyme Technical Committee),Other,Letter(s),2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:40:53Z,,0,0,09000064805a7f8c
FDA-1984-G-0019-0025,FDA,FDA-1984-G-0019,Letter from FDA/HFF-334 to Enzyme Technical Association,Other,Letter(s),2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:20:11Z,,0,0,09000064805a7f59
FDA-1984-G-0019-0006,FDA,FDA-1984-G-0019,Supplement from Ad Hoc Enzyme Technical Committee,Other,Supplement (SUP),2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:13:51Z,,0,0,09000064805a7f54
FDA-1984-G-0019-0034,FDA,FDA-1984-G-0019,Letter from FDA/HFF-333 to Enzyme Technical Association (c/o McKenna & Cuneo),Other,Letter(s),2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:37:27Z,,0,0,09000064805a7f6b
FDA-1984-G-0019-0023,FDA,FDA-1984-G-0019,Letter from FDA/HFF-334 to Enzyme Technical Association,Other,Letter(s),2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:20:10Z,,0,0,09000064805a7f5c
FDA-1984-G-0019-0011,FDA,FDA-1984-G-0019,Letter from PARKE-DAVIS & Company to FDA,Other,Letter(s),2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:13:52Z,,0,0,09000064805a7f4f
FDA-1984-G-0019-0145,FDA,FDA-1984-G-0019,Letter from Enzyme Technical Association to FDA,Other,Letter(s),2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:48:30Z,,0,0,09000064805a7fd7
FDA-1984-G-0019-0094,FDA,FDA-1984-G-0019,Memorandum from FDA/HFF-415 to FDA/HFF-334,Other,Memorandum,2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:43:52Z,,0,0,09000064805a7fa3
FDA-1984-G-0019-0117,FDA,FDA-1984-G-0019,Letter from Enzyme Technical Association to FDA,Other,Letter(s),2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:46:18Z,,0,0,09000064805a7fba
FDA-1984-G-0019-0170,FDA,FDA-1984-G-0019,"Tab 4  Enzyme Survey, Quality Assurance and Regulatory Affairs, Biotechnology Group, Miles Laboratories, Inc. re Comment from Enzyme Technical Association",Supporting & Related Material,Background Material,2016-08-03T04:00:00Z,2016,8,,,2016-08-03T15:55:04Z,,0,0,0900006481edfa9f
FDA-1984-G-0019-0160,FDA,FDA-1984-G-0019,Animal Enzymes re Supplement from Ad Hoc Enzyme Technical Committee,Supporting & Related Material,Background Material,2016-08-03T04:00:00Z,2016,8,,,2016-08-03T15:55:02Z,,0,0,0900006481eda4ea
FDA-1984-G-0019-0147,FDA,FDA-1984-G-0019,Letter from FDA/HFS-206 to Enzyme Technical Association,Other,Letter(s),2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:48:31Z,,0,0,09000064805a7fd9
FDA-1984-G-0019-0002,FDA,FDA-1984-G-0019,Notice of Filing of Petition for Affirmation of GRAS Status Ad Hoc Enzyme Technical Committee,Notice,Notice of Filing,2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:10:37Z,,0,0,09000064805a7f45
FDA-1984-G-0019-0005,FDA,FDA-1984-G-0019,Notice; AD HOC Enzyme Technical Committee; Amended Notice of Filing of Petition for Affirmation of GRAS Status,Notice,General Notice,2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,1984-10-30T04:59:59Z,2016-08-03T15:13:51Z,,0,0,09000064805a7f55
FDA-1984-G-0019-0110,FDA,FDA-1984-G-0019,Supplement from Genencor International Inc,Other,Supplement (SUP),2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:44:22Z,,0,0,09000064805a7fb3
FDA-1984-G-0019-0084,FDA,FDA-1984-G-0019,Memorandum of Meeting from FDA/HFF-335 to Ad Hoc Enzyme Technical Committee,Other,Memorandum,2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:43:02Z,,0,0,09000064805a7f99
FDA-1984-G-0019-0159,FDA,FDA-1984-G-0019,Enzyme Index re Supplement from Ad Hoc Enzyme Technical Committee,Supporting & Related Material,Background Material,2016-08-03T04:00:00Z,2016,8,,,2016-08-03T15:55:01Z,,0,0,0900006481eda4e7
FDA-1984-G-0019-0125,FDA,FDA-1984-G-0019,Memorandum of Telephone Conversation FDA/HFS-206 between Enzyme Technical Association,Other,Memorandum,2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:46:19Z,,0,0,09000064805a7fc2
FDA-1984-G-0019-0154,FDA,FDA-1984-G-0019,Memorandum from FDA/HFS-726 to Fred R. Shank,Other,Memorandum,2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:54:08Z,,0,0,09000064805a7fe1
FDA-1984-G-0019-0144,FDA,FDA-1984-G-0019,Letter from Enzyme Technical Association to FDA,Other,Letter(s),2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:48:30Z,,0,0,09000064805a7fd6
FDA-1984-G-0019-0083,FDA,FDA-1984-G-0019,Memorandum from FDA/HFF-159 to FDA/HFF-335,Other,Memorandum,2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:43:02Z,,0,0,09000064805a7f98
FDA-1984-G-0019-0078,FDA,FDA-1984-G-0019,Memorandum from FDA/HFF-144 to FDA/HFF-334,Other,Memorandum,2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:43:01Z,,0,0,09000064805a7f93
FDA-1984-G-0019-0071,FDA,FDA-1984-G-0019,Letter from FDA/HFF-1 to Ad Hoc Enzyme Technical Committee,Other,Letter(s),2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:40:55Z,,0,0,09000064805a7f7e
FDA-1984-G-0019-0087,FDA,FDA-1984-G-0019,Memorandum from FDA/HFF-158 to FDA/HFF-334,Other,Memorandum,2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:43:51Z,,0,0,09000064805a7f9c
FDA-1984-G-0019-0072,FDA,FDA-1984-G-0019,Letter from Enzyme Technical Association to FDA,Other,Letter(s),2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:43:00Z,,0,0,09000064805a7f8d
FDA-1984-G-0019-0026,FDA,FDA-1984-G-0019,"Letter from McKenna, Conner & Cuneo to FDA",Other,Letter(s),2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:20:11Z,,0,0,09000064805a7f58
FDA-1984-G-0019-0035,FDA,FDA-1984-G-0019,Letter from Enzyme Technical Association to FDA,Other,Letter(s),2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:37:27Z,,0,0,09000064805a7f6a
FDA-1984-G-0019-0022,FDA,FDA-1984-G-0019,Letter from Enzyme Technical Association,Other,Letter(s),2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:20:10Z,,0,0,09000064805a7f5d
FDA-1984-G-0019-0097,FDA,FDA-1984-G-0019,Memorandum from FDA/HFF-310 to FDA/HFF-334,Other,Memorandum,2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:43:53Z,,0,0,09000064805a7fa6
FDA-1984-G-0019-0105,FDA,FDA-1984-G-0019,Notice of Withdrawal re Affirmation of GRAS Status of Certain Enzymes,Notice,Withdrawal,2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:44:21Z,,0,0,09000064805a7fae
FDA-1984-G-0019-0132,FDA,FDA-1984-G-0019,Letter from Solvay Enzymes to FDA/HFF-333,Other,Letter(s),2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:48:29Z,,0,0,09000064805a7fc9
FDA-1984-G-0019-0126,FDA,FDA-1984-G-0019,Memorandum of Telephone Conversation FDA/HFS-206 & Enzyme Technical Association,Other,Memorandum,2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:46:20Z,,0,0,09000064805a7fc3
FDA-1984-G-0019-0077,FDA,FDA-1984-G-0019,Memorandum to FDA/HFF-152 to FDA/HFF-152,Other,Memorandum,2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:43:01Z,,0,0,09000064805a7f92
FDA-1984-G-0019-0076,FDA,FDA-1984-G-0019,Memorandum from FDA/HF-335 to FDA/BF-144,Other,Memorandum,2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:43:01Z,,0,0,09000064805a7f91
FDA-1984-G-0019-0064,FDA,FDA-1984-G-0019,Letter from FDA/HFF-335 to Industry Ad Hoc Technical Committee on Enzymes,Other,Letter(s),2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:40:54Z,,0,0,09000064805a7f85
FDA-1984-G-0019-0009,FDA,FDA-1984-G-0019,Memorandum of Meeting between FDA/HFF-335 & Miles Laboratories,Other,Memorandum,2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:13:52Z,,0,0,09000064805a7f51
FDA-1984-G-0019-0038,FDA,FDA-1984-G-0019,Letter from Enzyme Technical Association to FDA,Other,Letter(s),2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:37:27Z,,0,0,09000064805a7f67
FDA-1984-G-0019-0111,FDA,FDA-1984-G-0019,"Letter from FDA/HFS-216 to Genencor International Inc.,",Other,Letter(s),2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:44:22Z,,0,0,09000064805a7fb4
FDA-1984-G-0019-0075,FDA,FDA-1984-G-0019,Memorandum from FDA/HF-335 to FDA/BF-152,Other,Memorandum,2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:43:01Z,,0,0,09000064805a7f90
FDA-1984-G-0019-0043,FDA,FDA-1984-G-0019,Letter from Wallerstein Company to FDA,Other,Letter(s),2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:39:11Z,,0,0,09000064805a7f7c
FDA-1984-G-0019-0046,FDA,FDA-1984-G-0019,Letter from FDA/BF-335 to Ad Hoc Enzyme Technical Committee,Other,Letter(s),2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:39:12Z,,0,0,09000064805a7f79
FDA-1984-G-0019-0052,FDA,FDA-1984-G-0019,Letter from Wallerstein Company to FDA,Other,Letter(s),2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:39:13Z,,0,0,09000064805a7f73
FDA-1984-G-0019-0007,FDA,FDA-1984-G-0019,Supplement from NOVO Laboratories Inc. re Affirmation of GRAS Status of Certain Enzymes,Other,Supplement (SUP),2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:13:52Z,,0,0,09000064805a7f53
FDA-1984-G-0019-0099,FDA,FDA-1984-G-0019,Memo to the File re Affirmation of GRAS Status of Certain Enzymes,Other,Memo,2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:43:53Z,,0,0,09000064805a7fa8
FDA-1984-G-0019-0096,FDA,FDA-1984-G-0019,Memorandum from FDA/HFF-304 to FDA/HFF-334,Other,Memorandum,2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:43:53Z,,0,0,09000064805a7fa5
FDA-1984-G-0019-0167,FDA,FDA-1984-G-0019,"Tab 1 Introduction Biotechnology Group, Miles Laboratories, Inc. re Comment from Enzyme Technical Association",Supporting & Related Material,Background Material,2016-08-03T04:00:00Z,2016,8,,,2016-08-03T15:55:03Z,,0,0,0900006481edfa9b
FDA-1984-G-0019-0166,FDA,FDA-1984-G-0019,Table of Contents Tab 1 - Tab 5 re Comment from Enzyme Technical Association,Supporting & Related Material,Background Material,2016-08-03T04:00:00Z,2016,8,,,2016-08-03T15:55:03Z,,0,0,0900006481edfa9a
FDA-1984-G-0019-0161,FDA,FDA-1984-G-0019,Plant Enzymes re Supplement from Ad Hoc Enzyme Technical Committee,Supporting & Related Material,Background Material,2016-08-03T04:00:00Z,2016,8,,,2016-08-03T15:55:02Z,,0,0,0900006481eda4eb
FDA-1984-G-0019-0162,FDA,FDA-1984-G-0019,Microbial Enzymes re Supplement from Ad Hoc Enzyme Technical Committee,Supporting & Related Material,Background Material,2016-08-03T04:00:00Z,2016,8,,,2016-08-03T15:55:02Z,,0,0,0900006481eda4ec
FDA-1984-G-0019-0138,FDA,FDA-1984-G-0019,Memorandum of Meeting between FDA/HFS-206 & McKenna & Cuneo,Other,Memorandum,2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:48:29Z,,0,0,09000064805a7fcf
FDA-1984-G-0019-0134,FDA,FDA-1984-G-0019,Letter from Solvay Enzymes to Keller and Heckman,Other,Letter(s),2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:48:29Z,,0,0,09000064805a7fcb
FDA-1984-G-0019-0128,FDA,FDA-1984-G-0019,Letter from Enzyme Technical Association to FDA,Other,Letter(s),2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:46:20Z,,0,0,09000064805a7fc5
FDA-1984-G-0019-0118,FDA,FDA-1984-G-0019,Supplement from Enzyme Technical Association re Docket No. 84G-0257 GRAS Petition No. 3G0016 on Affirmation of GRAS Status of Certain Enzymes,Other,Supplement (SUP),2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:46:18Z,,0,0,09000064805a7fbb
FDA-1984-G-0019-0143,FDA,FDA-1984-G-0019,Letter from Enzyme Technical Association to FDA,Other,Letter(s),2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:48:30Z,,0,0,09000064805a7fd5
FDA-1984-G-0019-0171,FDA,FDA-1984-G-0019,"Tab 5 Determining The Safety of Enzymes Used in Food Processing,  Department of Food Microbiology and Toxicology University of Wisconsin and Food Research Institute re Comment from Enzyme Technical Association",Supporting & Related Material,Background Material,2016-08-03T04:00:00Z,2016,8,,,2016-08-03T15:55:04Z,,0,0,0900006481edfaa0
FDA-1984-G-0019-0079,FDA,FDA-1984-G-0019,Memorandum from FDA/HFF-152 to FDA/HFF-335,Other,Memorandum,2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:43:01Z,,0,0,09000064805a7f94
FDA-1984-G-0019-0042,FDA,FDA-1984-G-0019,Letter from FDA/BF-335 to Ad Hoc Enzyme Technical Committee,Other,Letter(s),2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:39:11Z,,0,0,09000064805a7f7d
FDA-1984-G-0019-0044,FDA,FDA-1984-G-0019,Letter from FDA/BF-335 to Parke-Davis & Company,Other,Letter(s),2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:39:11Z,,0,0,09000064805a7f7b
FDA-1984-G-0019-0060,FDA,FDA-1984-G-0019,Letter from FDA/HFF-335 to Ad Hoc Enzyme Technical Committee,Other,Letter(s),2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:40:54Z,,0,0,09000064805a7f89
FDA-1984-G-0019-0069,FDA,FDA-1984-G-0019,Letter from Ad Hoc Enzyme Technical Committee to FDA,Other,Letter(s),2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:40:55Z,,0,0,09000064805a7f80
FDA-1984-G-0019-0055,FDA,FDA-1984-G-0019,Letter from Miles Laboratories Inc.,Other,Letter(s),2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:39:13Z,,0,0,09000064805a7f70
FDA-1984-G-0019-0088,FDA,FDA-1984-G-0019,Memorandum from FDA/HFF-458 to FDA/HFF-334,Other,Memorandum,2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:43:51Z,,0,0,09000064805a7f9d
FDA-1984-G-0019-0008,FDA,FDA-1984-G-0019,Supplement from Ad Hoc Enzyme Technical Committee,Other,Supplement (SUP),2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:13:52Z,,0,0,09000064805a7f52
FDA-1984-G-0019-0010,FDA,FDA-1984-G-0019,Letter from FDA/HFF-335 to Ad Hoc Enzyme Technical Committee,Other,Letter(s),2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:13:52Z,,0,0,09000064805a7f50
FDA-1984-G-0019-0100,FDA,FDA-1984-G-0019,Memorandum of Meeting between FDA/HFF-335 and Industry,Other,Memorandum,2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:43:53Z,,0,0,09000064805a7fa9
FDA-1984-G-0019-0098,FDA,FDA-1984-G-0019,Memo to the File re Affirmation of GRAS Status of Certain Enzymes,Other,Memo,2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:43:53Z,,0,0,09000064805a7fa7
FDA-1984-G-0019-0121,FDA,FDA-1984-G-0019,Letter from FDA/HFS-216 to Enzyme Technical Association,Other,Letter(s),2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:46:19Z,,0,0,09000064805a7fbe
FDA-1984-G-0019-0175,FDA,FDA-1984-G-0019,"Toxicological evaluation of some enzymes, modified starches
and certain other substances re Letter from Wallerstein Company to FDA",Supporting & Related Material,Background Material,2016-08-03T04:00:00Z,2016,8,,,2016-08-03T15:55:05Z,,0,0,0900006481f37de6
FDA-1984-G-0019-0174,FDA,FDA-1984-G-0019,Background Material re Enzyme Preparations from Animal and Plant Sources; Affirmation of GRAS Status As Direct Food Ingredients,Supporting & Related Material,Background Material,2016-08-03T04:00:00Z,2016,8,,,2016-08-03T15:55:05Z,,0,0,0900006481f23ae7